Home News center news information 2017 in vitro diagnostics industry three new board listed companies
2017/12/28
2017 in vitro diagnostics industry three new board listed companies

In April 9, 2015, Shanxi Yasen industrial Limited by Share Ltd has been listed, the total share capital of 10 million 10 thousand shares. Shanxi Yasen Industrial Co., Ltd. was established in October 1998, is a set of medical equipment development, production, sales and service as one of the medical equipment enterprises. The company has 5 categories of 10 kinds of products, the main products for urine analyzer, blood coagulation analyzer, blood rheology analyzer, micro image analysis system, gold standard test instrument and other products.


4, Henan Kang qualied (832350)
In April 23, 2015, Henan Shuguang qualied Kang biological Polytron Technologies Inc listed on the new board, the total share capital of 6 million shares. Dawn quali Kang was established in 2011, is mainly engaged in research and development, production and sales of clinical laboratory instruments and reagents, is a with independent intellectual property rights, 6 kinds of specifications of automatic biochemical analyzer, 50 kinds of in vitro diagnostic reagents enterprise production.


5, Guangzhou wondfo Biology (300482)
June 30th wondfo bio listed. The company formerly known as wondfo Co., founded in November 13, 1992. Attention to the rapid diagnosis reagent, rapid detection instrument POCT related products R & D, production and sales, build a relatively perfect colloidal gold and latex marked chromatography technology platform, fluorescence quantitative detection technology platform, dry biochemical electrochemical quantitative detection technology platform, and relying on the three technology platform covering the formation of pregnancy detection, infectious disease detection, drug (drug abuse) detection, chronic disease detection and other fields of rich product line, products widely used on bedside detection, clinical testing, on-site inspection and personal health management etc..


6, Guangzhou dagro Biology (832705)
July 9th Darryl biological officially listed on the National SME share transfer system. Darryl biology was established on August 11, 2003, the tat gene holding subsidiaries, Darryl biological main business for quantitative immunoassay and eugenics in the field of diagnostic reagents and related equipment R & D, production and sales, the main products mainly includes two kinds of reagent and instrument, reagent is mainly take the time resolution fluorescence immunoassay kit for detection of production technology. Instruments mainly supporting the main products of the analysis and testing equipment.


8, Beijing, and (833729)
On October 20, bulletin of national small and medium-sized enterprises share transfer system display, nzi and listing application is approved, and in today's public transfer. The company was founded in May 4, 2011, the main business for the production and sale of in vitro diagnostic reagents.


9, Beijing Compulife gene (834367)
November 17th U.S. KINGE listed three new board. Set up the company in 2005, is headquartered in Beijing, China, Qixia has a number of subsidiaries, and the establishment of R & D centers in the United States in the United States North Carolina State biotechnology Triangle Park. Meikang gene scientific attention for in vitro diagnostic technology of independent research and development and innovation, has formed three series of diagnostic reagents for gene platform and related testing services, immune system diagnostic reagents, testing equipment.


10, Zhuhai Sai Le Qi (834496)
In December 2nd, Zhuhai, the music of the biotechnology Limited by Share Ltd (securities referred to: the securities code: 834496) by means of the transfer of the agreement in the national share transfer system listed on the transfer. Founded in August 2005, is mainly engaged in the development, production and sales of in vitro diagnostic reagents. The company's products are mainly used to guide clinical gene diagnosis of individual treatment of patients, and provide the corresponding supporting technology and services.


11, Jiang River in Shanghai (834839)
December 14th news, the National SME share transfer system announcement shows that the listing application of the river to get approval, and in today's public transfer. Jiang biological (Shanghai River Biological Polytron Technologies Inc) was founded in April 18, 2005, mainly engaged in research and development, production and marketing of molecular diagnostic reagents. At present, the river has made molecular diagnostic reagents product registration certificate 25, nucleic acid automatic extraction equipment and other products registration certificate 6, there are more than 200 products to obtain the EU CE certification.